SCM
PFE icon

Sitrin Capital Management’s Pfizer PFE Stock Holding History

Sitrin Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-135,844
Closed -$4.67M – 41
2017
Q4 		$4.67M Sell
135,844
-1,914
-1% -$65.3K 2.95% 19
2017
Q3 		$4.67M Sell
137,758
-995
-0.7% -$32K 3% 17
2017
Q2 		$4.42M Buy
138,753
+2,456
+2% +$77.5K 3% 20
2017
Q1 		$4.42M Buy
+136,297
New +$4.3M 3.18% 18

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Sitrin Capital Management's PFE Position: Q1 2018 in Review

Sitrin Capital Management sold out of Pfizer (PFE) in Q1 2018, closing a stake of 135,844 shares — an estimated $4.67M sold.

Sitrin Capital Management first reported a position in PFE in Q1 2017 and held it in 4 quarters. The position peaked at $4.67M in Q4 2017. 2,229 funds tracked by Wall St. Rank hold PFE as of Q1 2018.

  • Sitrin Capital Management reported no remaining Pfizer position as of Q1 2018 after selling out during the quarter.
  • Sitrin Capital Management sold 135,844 Pfizer shares in Q1 2018, an estimated $4.67M.
  • Sitrin Capital Management first reported a position in Pfizer in Q1 2017 and held it in 4 quarters.
  • Sitrin Capital Management's Pfizer position peaked at $4.67M in Q4 2017.
  • 2,229 funds tracked by Wall St. Rank held Pfizer as of Q1 2018.

Based on Sitrin Capital Management's 13F filing for Q1 2018, filed 17 Apr 2018.